Atom Therapeutics
China - Suzhou
BiotechnologyFocus: Small molecules for metabolic diseases
Atom Therapeutics is a life sciences company focused on Small molecules for metabolic diseases.
Metabolic Diseases
Funding Stage
SERIES C +
Open Jobs
0
Pipeline & Clinical Trials
ABP-671
HyperuricemiaClinical Trials (1)
NCT04060173A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
Phase 1ABP-671
GoutClinical Trials (1)
NCT03906006A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects
Phase 1ABP-745
GoutClinical Trials (1)
NCT06258213A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers
Phase 1ABP-671 plus allopurinol
Gout ChronicClinical Trials (1)
NCT07367971Drug-Drug Interaction Study of ABP-671 in Gout Patients
Phase 1ABP-671
GoutClinical Trials (1)
NCT04303039Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects
Phase 1ABP-671
GoutClinical Trials (1)
NCT04638543A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia
Phase 2ABP-671 plus febuxostat Group 1
Chronic Kidney DiseaseClinical Trials (1)
NCT07323095Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
Phase 2ABP-745 Dose A
Acute Gouty ArthritisClinical Trials (1)
NCT07145229Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Phase 2ABP-745 Dose A
Atherosclerosis Cardiovascular DiseaseClinical Trials (1)
NCT07303777Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
Phase 2ABP-671
GoutClinical Trials (1)
NCT05818085Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
Phase 2/3ABP-671
GoutClinical Trials (1)
NCT06276556Extension Study of ABP-671 in Participants With Gout
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2012
Portfolio: 11 clinical trials